Sumiki's acid
|
Basic information |
| Metabolite name | Sumiki's acid |
 | HMDB0002432 |
 |
C20448 |
 |
80642 |
| Synonyms | 5-Hydroxymethyl-2-furoic acid; |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Sumiki's acid |
| HMDB0002432 |
|
C20448 |
|
80642 |
| Synonyms | 5-Hydroxymethyl-2-furoic acid; |
| No. of studies | 4 |
|
Relationship between Sumiki's acid and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M063 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M063 | Type2 | CUMS + high dose of the sea buckthorn seed oil group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M063 | Type2 | CUMS + low dose group of the sea buckthorn seed oil group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M063 | Type2 | CUMS + middle dose of the sea buckthorn seed oil group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M619 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M619 | Type2 | CUMS + middle dose of Jiaotaiwan group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Up |
| Study M951 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M951 | Type2 | CUMS + paeoniflorin group vs. CUMS group | Urine | Sprague-Dawley rat | Up |